High-grade squamous intraepithelial lesion (HSIL) encompasses the conditions previously termed cervical intraepithelial neoplasia grades 2 and 3 (CIN 2 and CIN 3), moderate and severe dysplasia, and carcinoma in situ. HSIL is a squamous cell abnormality associated with human papillomavirus (HPV). Though not all HSILs will progress to cancer, HSIL is considered a precancerous lesion and is usually treated aggressively. The epidemiology, risk factors, and clinical presentation of HSILs are discussed. Participants will understand current diagnostic techniques, including cervical cytology, human papillomavirus (HPV) testing, and colposcopy, enabling clinicians to accurately identify and classify HSILs. Management strategies for HSILs, including both surgical and non-surgical approaches, will be addressed.This activity also reviews the interprofessional team’s role in managing this condition. Healthcare professionals will enhance their skills and knowledge in diagnosing and treating HSILs, ultimately improving patient outcomes and reducing the burden of cervical cancer.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/22882
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cytopathology, General Surgery, Internal Medicine